Roland P. Kuiper

10.8k citations

123 papers · 5.4k indexed · 3 hit papers · h-index 35

Molecular Biology top 2%
Hematology top 0.5%
Public Health, Environmental and Occupational Health top 1%
Cancer Research top 1%
Oncology top 2%

Co-authors: Ad Geurts van Kessel Marjolijn J. L. Ligtenberg Nicoline Hoogerbrugge Peter M. Hoogerbrugge Frank N. van Leeuwen Marion Massop Saskia Langemeijer Théo de Witte
Topics: Acute Lymphoblastic Leukemia research (39 papers)Cancer Genomics and Diagnostics (26 papers)Genetic factors in colorectal cancer (21 papers)
Cited by: Hematology Cancer Research Pathology and Forensic Medicine
Journals: Science Nucleic Acids Research Nature Communications
Partner nations: Netherlands Germany United States

In The Last Decade

Roland P. Kuiper

118 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Acquired mutations in TET2 are common in myelodysplastic syndromes

2009 548 citations Roland P. Kuiper, Ad Geurts van Kessel et al. profile →
Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1

2008 546 citations Roland P. Kuiper, Ad Geurts van Kessel et al. profile →
Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes

2010 541 citations Roland P. Kuiper et al. profile →

Peers

Countries citing papers authored by Roland P. Kuiper

Since Specialization

Citations

This map shows the geographic impact of Roland P. Kuiper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roland P. Kuiper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roland P. Kuiper more than expected).

Fields of papers citing papers by Roland P. Kuiper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roland P. Kuiper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roland P. Kuiper. The network helps show where Roland P. Kuiper may publish in the future.

Co-authorship network of co-authors of Roland P. Kuiper

This figure shows the co-authorship network connecting the top 25 collaborators of Roland P. Kuiper. A scholar is included among the top collaborators of Roland P. Kuiper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roland P. Kuiper. Roland P. Kuiper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Unraveling mutagenic processes influencing the tumor mutational patterns of individuals with constitutional mismatch repair deficiency 2025 ·Nature Communications ·(unknown),(unknown),(unknown),Mark A.J. Gorris,Gerty Schreibelt,Sjors Middelkamp,Arjen R. Mensenkamp,Reno S. Bladergroen,Kiek Verrijp,Nicoline Hoogerbrugge,Pieter Wesseling,Rachel S. van der Post,Jan Loeffen,Corrie Gidding,(unknown),I. Jolanda M. de Vries,Ruben van Boxtel,Richarda M. de Voer,Marjolijn C.J. Jongmans,Roland P. Kuiper	2
2	Novel Findings in Pediatric and Adolescent Patients With Cancer and a Germline SMARCA4 Variant 2025 ·Pediatric Blood & Cancer ·(unknown),Ronald R. de Krijger,(unknown),Lennart Kester,Saskia Hopman,Mariëtte E.G. Kranendonk,Marijn A. Vermeulen,Carli Tops,Seok‐Young Kim,Hans Clevers,Kornelia Neveling,Roland P. Kuiper,Marjolijn C.J. Jongmans	0
3	Molecular analysis of cancer genomes in children with Lynch syndrome: Exploring causal associations 2024 ·International Journal of Cancer ·(unknown),Steffen Hirsch,(unknown),(unknown),Lennart Kester,Mariëtte E.G. Kranendonk,Laura S. Hiemcke‐Jiwa,Evelien de Vos‐Kerkhof,Jan Loeffen,Robert J. Autry,Kristian W. Pajtler,Natalie Jäger,Marjolijn C.J. Jongmans,Roland P. Kuiper	4
4	Update on Recommendations for Surveillance for Children with Predisposition to Hematopoietic Malignancy 2024 ·Clinical Cancer Research ·Luke Maese,Marcin W. Włodarski,(unknown),Alison A. Bertuch,Gaëlle Bougeard,Vivian Y. Chang,Lucy A. Godley,Payal P. Khincha,Roland P. Kuiper,Harry Lesmana,Rose B. McGee,Lisa J. McReynolds,(unknown),Sharon E. Plon,Sharon A. Savage,Sarah Scollon,Hamish S. Scott,Michael F. Walsh,Kim E. Nichols,Christopher C. Porter	3
5	Pediatric Cancer Screening in Hereditary Gastrointestinal Cancer Risk Syndromes: An Update from the AACR Childhood Cancer Predisposition Working Group 2024 ·Clinical Cancer Research ·Suzanne P. MacFarland,(unknown),Kami Wolfe Schneider,Roland P. Kuiper,Harry Lesmana,(unknown),Kim E. Nichols,Christopher C. Porter,Sharon A. Savage,Kris Ann P. Schultz,Hamish S. Scott,Lisa J. States,Uri Tabori,Chieko Tamura,Gail E. Tomlinson,Kristin Zelley,Carol Durno,Andrew J. Bauer,Sharon E. Plon	6
6	T-cell lymphoblastic lymphoma compared with T-cell acute lymphoblastic leukemia: similar subtypes and different fusions 2024 ·PubMed ·(unknown),(unknown),(unknown),Reno S. Bladergroen,Lennart Kester,Marijn A. Vermeulen,Freerk van Dijk,Jules P.P. Meijerink,Roland P. Kuiper,Jan Loeffen	2
7	Mutational mechanisms in multiply relapsed pediatric acute lymphoblastic leukemia 2024 ·Leukemia ·(unknown),(unknown),(unknown),Željko Antić,Stefan H. Lelieveld,Marley Yeong,Liset Westera,Edwin Sonneveld,Peter M. Hoogerbrugge,Vincent H. J. van der Velden,Frank N. van Leeuwen,Roland P. Kuiper	3
8	Assessment of Cancer Predisposition Syndromes in a National Cohort of Children With a Neoplasm 2023 ·JAMA Network Open ·(unknown),Saskia Hopman,Machteld I. Bosscha,Charlotte J. Dommering,Marry M. van den Heuvel‐Eibrink,Janna A. Hol,Lennart Kester,Marco J. Koudijs,Karin P.S. Langenberg,Jan Loeffen,Jasper van der Lugt,Annette C. Moll,Max M. van Noesel,(unknown),Evelien de Vos‐Kerkhof,Johannes H. M. Merks,Roland P. Kuiper,Marjolijn C.J. Jongmans	19
9	Elevated enhancer-oncogene contacts and higher oncogene expression levels by recurrent CTCF inactivating mutations in acute T cell leukemia 2023 ·Cell Reports ·Willem K. Smits,Carlo Vermeulen,(unknown),Shunsuke Kimura,Eric Vroegindeweij,Jessica G. C. A. M. Buijs-Gladdines,(unknown),Marjon J.A.M. Verstegen,Erik Splinter,Simon V. van Reijmersdal,Arjan Buijs,Niels Galjart,(unknown),Max van Min,Roland P. Kuiper,Patrick Kemmeren,Charles G. Mullighan,Wouter de Laat,Jules P.P. Meijerink	5
10	¹⁸F‐FDG‐PET/CT imaging in diagnostic workup of pediatric precursor B‐cell lymphoblastic lymphoma 2023 ·Pediatric Blood & Cancer ·(unknown),Laura Padilla,Birgit Burkhardt,Andishe Attarbaschi,(unknown),Rejin Kebudi,Rutger A. J. Nievelstein,Nelleke Tolboom,Melanie M. Hagleitner,Roland P. Kuiper,Auke Beishuizen,Jan Loeffen	2
11	The role of cancer predisposition syndrome in children and adolescents with very rare tumours 2023 ·SHILAP Revista de lepidopterología ·Daniel Orbach,Ines B. Brecht,Nadège Corradini,(unknown),Jelena Roganović,Franck Bourdeaut,Yves Réguerre,Roland P. Kuiper,Brigitte Bressac–de Paillerets,Andrea Ferrari,Calogero Virgone,Jan Godziński,Gianni Bisogno,Léa Guerrini‐Rousseau,Nuno Jorge Farinha,Luca Bergamaschi,Ewa Bień,Michaela Kuhlen,Dominik T. Schneider,Tal Ben Ami	3
12	BTK inhibition sensitizes acute lymphoblastic leukemia to asparaginase by suppressing the amino acid response pathway 2021 ·Blood ·Miriam Butler,Dorette S. van Ingen Schenau,Jiangyan Yu,Silvia Jenni,Maria Pamela Dobay,(unknown),(unknown),(unknown),Fieke W. Hoff,Jules P.P. Meijerink,Steven M. Kornblau,Beat Bornhäuser,Jean‐Pierre Bourquin,Roland P. Kuiper,Laurens T. van der Meer,Frank N. van Leeuwen	17
13	Challenges of Neoantigen Targeting in Lynch Syndrome and Constitutional Mismatch Repair Deficiency Syndrome 2021 ·Cancers ·(unknown),Mark A.J. Gorris,(unknown),Marjolijn C.J. Jongmans,(unknown),Roland P. Kuiper,Richarda M. de Voer,Nicoline Hoogerbrugge,Gerty Schreibelt,I. Jolanda M. de Vries	5
14	Clinical and Molecular Characteristics and Outcome of Cystic Partially Differentiated Nephroblastoma and Cystic Nephroma: A Narrative Review of the Literature 2021 ·Cancers ·(unknown),(unknown),Ronald R. de Krijger,Marjolijn C.J. Jongmans,Roland P. Kuiper,Marc R. Liliën,Martine van Grotel,Norbert Graf,Marry M. van den Heuvel‐Eibrink,Janna A. Hol	11
15	Use of CRISPR-modified human stem cell organoids to study the origin of mutational signatures in cancer 2017 ·Science ·Jarno Drost,Ruben van Boxtel,Francis Blokzijl,Tomohiro Mizutani,Nobuo Sasaki,Valentina Sasselli,Joep de Ligt,Sam Behjati,Judith E. Grolleman,Tom van Wezel,Serena Nik‐Zainal,Roland P. Kuiper,Edwin Cuppen,Hans Clevers	312
16	Accurate detection of low-level mosaic mutations in pediatric acute lymphoblastic leukemia using single molecule tagging and deep-sequencing 2017 ·Leukemia & lymphoma ·Jiangyan Yu,Željko Antić,Simon V. van Reijmersdal,Alexander Hoischen,Edwin Sonneveld,Esmé Waanders,Roland P. Kuiper	5
17	A CRISPR/Cas9 Based Kinome Screen Identifies Bruton Tyrosine Kinase (BTK) As an Important Determinant of Asparaginase Treatment Response in Acute Lymphoblastic Leukemia 2017 ·Blood ·Miriam Butler,(unknown),Jiangyan Yu,Silvia Jenni,Maria Pamela Dobay,Peter M. Hoogerbrugge,Beat Bornhäuser,Jean‐Pierre Bourquin,Roland P. Kuiper,Frank N. van Leeuwen	2
18	Perivascular Epithelioid Cell Tumor of Gastrointestinal Tract 2015 ·Medicine ·(unknown),Chenliang Wang,Junxiao Zhang,Roland P. Kuiper,Minmin Song,Xiaoli Zhang,(unknown),Ad Geurts van Kessel,Aikichi Iwamoto,Jianping Wang,Huanliang Liu	11
19	Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL 2013 ·Blood ·Arian van der Veer,Esmé Waanders,Rob Pieters,Marieke E. Willemse,Simon V. van Reijmersdal,Lisa J. Russell,Christine J. Harrison,William E. Evans,Vincent H. J. van der Velden,Peter M. Hoogerbrugge,Frank N. van Leeuwen,Gabriele Escherich,Martin A. Horstmann,(unknown),Dimitris Rizopoulos,Hester A. de Groot‐Kruseman,Edwin Sonneveld,Roland P. Kuiper,Monique L. den Boer	187
20	Late Recurrence of Childhood T-Cell Acute Lymphoblastic Leukemia Frequently Represents a Second Leukemia Rather Than a Relapse: First Evidence for Genetic Predisposition 2011 ·Journal of Clinical Oncology ·Tomasz Szczepański,Vincent H. J. van der Velden,Esmé Waanders,Roland P. Kuiper,Pieter Van Vlierberghe,Bernd Gruhn,Cornelia Eckert,Renate Panzer‐Grümayer,Giuseppe Basso,Hélène Cavé,Udo zur Stadt,Dario Campana,André Schrauder,Rosemary Sutton,(unknown),Jules P.P. Meijerink,Jacques J. M. van Dongen	51

About Roland P. Kuiper

Roland P. Kuiper is a scholar working on Hematology, Cancer Research and Pathology and Forensic Medicine, having authored 123 papers that have together received 5.4k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (39 papers), Cancer Genomics and Diagnostics (26 papers) and Genetic factors in colorectal cancer (21 papers). The work is most often cited by research in Hematology (1.5k citations), Cancer Research (1.1k citations) and Pathology and Forensic Medicine (1.1k citations). Roland P. Kuiper has collaborated with scholars based in Netherlands, Germany and United States. Frequent co-authors include Ad Geurts van Kessel, Marjolijn J. L. Ligtenberg, Nicoline Hoogerbrugge, Peter M. Hoogerbrugge, Frank N. van Leeuwen, Marion Massop, Saskia Langemeijer, Théo de Witte, Joop H. Jansen and Peter Vandenberghe. Their work appears in journals such as Science, Nucleic Acids Research and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact